PlasmaKonzentr

PlasmaKonzentr is a German-based company specializing in the production and distribution of plasma-derived medical products. Founded in the early 2000s, the company focuses on providing high-quality plasma components for therapeutic use, particularly in the fields of hematology, immunology, and critical care medicine. Its primary offerings include albumin, immunoglobulins, and coagulation factors, which are essential for treating various medical conditions such as immune deficiencies, bleeding disorders, and severe infections.

The company sources its plasma from carefully selected donors who undergo rigorous screening to ensure safety and compliance with international health standards. PlasmaKonzentr adheres to strict regulatory guidelines, including those set by the European Medicines Agency (EMA) and the World Health Organization (WHO), to maintain product integrity and patient safety. Its manufacturing facilities are equipped with advanced technologies to ensure purity, efficacy, and consistency in its products.

PlasmaKonzentr operates within a global market, supplying hospitals, clinics, and pharmaceutical companies across Europe and beyond. The company emphasizes transparency in its supply chain, working closely with healthcare providers to address medical needs while promoting responsible plasma donation practices. Additionally, it participates in research initiatives to innovate and improve plasma-derived therapies, contributing to advancements in patient care.

With a commitment to quality and ethical sourcing, PlasmaKonzentr plays a significant role in supporting healthcare systems by providing critical plasma-based treatments that enhance patient outcomes.